Helicobacter Pylori Diagnostics Market Size
| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| CAGR | 7.20% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Helicobacter Pylori Diagnostics Market Analysis
The Global Helicobacter Pylori Diagnostics Market is expected to register a CAGR of 7.2% during the forecast period.
The outbreak of the COVID-19 pandemic has pushed the medical device industry into action, with a race to develop both therapeutic and preventive devices. Exponentially increasing cases of the coronavirus worldwide are leading to the need for the development of novel treatments, with several clinical trials underway. Meanwhile, the manufacturers of diagnostic devices were highly focused on developing vaccines and drugs, which can also be applied in the diagnosis and treatment of COVID-19, increasing the rate of clinical trials to a great extent. The outbreak of the pandemic increased the cases of gastrointestinal diseases and other infectious diseases. For instance, as per the study titled, "Impact of Gastrointestinal Symptoms in COVID-19: a Molecular Approach" published in November 2020, the gastrointestinal tract gets affected by COVID-19. It also reported that the gastrointestinal tract is considered the replication site for SARS-CoV-2. In addition, it also stated that the severity in patients suffering from COVID-19 increases who are already having gastrointestinal disorders. Helicobacter pylori diagnostics is one of the common diagnostic procedures for gastrointestinal disorders, therefore, the market witnessed a considerable growth during the pandemic.
The rising prevalence of infectious diseases and increasing awareness about the infections among people are the major drivers for the market. The most common infectious diseases caused by bacteria are Tuberculosis, Chlamydia, gonorrhea, other sexually transmitted diseases (STDs), Stomach flu (gastroenteritis), and Urinary tract infections (UTIs). For instance, according to the study titled, "The Global Prevalence of Peptic Ulcer in the World: a Systematic Review and Meta-analysis" published in December 2021, the global prevelence of peptic ulcer was around 8.4% in 2021. Similarly, as per the report published by the Medscape in April 2021, peptic ulcer disease affects approximately 4.6 million people annually in the United States. Similarly, according to the report published by the European Centre for Disease Prevention and Control in March 2021, it was reported that every year around 500,000 sexually transmitted infections are detected in the European Union, European Economic Area (EEA), and the United Kingdom. Since, helicobacter pylori diagnostics are generally recommended for the diagnostic of infectious diseases, therefore, such instances indicate that the market is expected to show significant growth rate over the forecast period.
However, stringent regulatory norms by government may likely to restrain the market growth over the forecast period.
Helicobacter Pylori Diagnostics Market Trends
Immunoassay Segment is Expected to Witness Growth Over the Forecast Period
An immunoassay is a test that relies on biochemistry to measure the presence and concentration of an analyte. The analyte can be large proteins, antibodies that a person has produced as a result of an infection, or small molecules. Immunoassays are highly sensitive and specific. Their high specificity results from the use of antibodies and purified antigens as reagents. This assay can be used for the diagnosis of a disease directly, by measuring the presence of antigens. In addition, it is a highly selective bioanalytical method that measures the presence or concentration of analytes ranging from small molecules to macromolecules in solution using an antibody or antigen as a biorecognition agent.
The immunoassay segment holds a significant market share in the helicobacter pylori diagnostics market and is anticipated to show a similar trend over the forecast period due to the presence of several advanced technologies such as the enzyme immunoassays which are used for the detection of antibodies. The rising prevalence of Helicobacter pylori infections and gastritis and technological advancements are the key driving factors in the immunoassay segment. For instance, as per the study titled, "Diagnosis of Helicobacter pylori Infection and Recent Advances" published in August 2021, the prevalence of gastritis was around 50.0%, which was shown from 40.7% to 56.0% and it included 20.0%-30.0% of chronic atrophic gastritis, globally in 2021. It also reported that Helicobacter pylori infection is generally consistent with the prevalence of gastritis and Helicobacter pylori positive gastritis generally accounts for more than 80.0%. Immunoassays are generally used for the detection of such infections, therefore, increasing cases of Helicobacter pylori infection and gastritis are anticipated to propel the segment growth over the forecast period.
North America is Expected to Dominate the Helicobacter Pylori Diagnostics Market
North America is expected to dominate the overall helicobacter pylori diagnostics market over the forecast period. The growth is due to factors such as the increasing number of cases of infectious diseases, increasing awareness of infectious diseases, and new product launches. For instance, in June 2021, Biomerica Inc. announced that it has signed an exclusive five-year distribution agreement with a Canadian partner for the distribution and marketing of Biomerica's new and proprietary Helicobacter pylori test, called hp+detect. The hp+detect product has been developed for the identification and monitoring of helicobacter pylori infection, the leading cause of duodenal and gastric ulcers, and a contributing risk factor associated with gastric cancer. Therefore, such instances are anticipated to propel market growth in the North America region.
Key product launches, high concentration of market players or manufacturer's presence, and acquisition & partnerships among major players, and increasing cases of gastrointestinal disorders in the United States are some of the factors driving the growth of the Helicobacter pylori diagnostics market in the country. For instance, as per the journal published by the Cleveland Clinic Organization in September 2020, acute gastritis affects about 8 out of every 1,000 people in the United States every year. It also reported that chronic, long-term gastritis is less common and it affects approximately 2 out of 10,000 people in the United States every year.
Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.
Helicobacter Pylori Diagnostics Industry Overview
The helicobacter pylori diagnostics market is consolidated and consists of a few major players. In terms of market share, a few of the major players are currently dominating the market. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known including Thermo Fisher Scientific, Bio-Rad Laboratories, Quest Diagnostics Incorporate, Meridian Bioscience, F. Hoffmann-La Roche, Biohit Oyj, CorisBioConcept SPRL, CerTest BIOTEC, Epitope Diagnostics, Inc and Exalenz Bioscience Ltd among others.
Helicobacter Pylori Diagnostics Market Leaders
-
Thermo Fisher Scientific
-
Quest Diagnostics Incorporate
-
Meridian Bioscience
-
Bio-Rad Laboratories
-
CerTest BIOTEC
- *Disclaimer: Major Players sorted in no particular order
Helicobacter Pylori Diagnostics Market News
- In May 2022, Biomerica, Inc. announced CE Mark for its hp+detect diagnostic test that detects Helicobacter pylori bacteria. The company will begin to market and sell its hp+detect diagnostic test in the European Union (EU) and other international countries following the registration of the product in each country in which it is sold.
- In April 2021, Otsuka launched QuickNaviTM-H.pylori, a Helicobacter pylori Quick Detection Kit. The diagnostic kit utilizes the immunochromatography method to confirm the presence or absence of Helicobacter pylori antigens in a stool sample. The test kit will be used in medical institutions and enables a rapid evaluation in eight minutes by the addition of three drops of sample liquid to the kit.
Helicobacter Pylori Diagnostics Industry Segmentation
As per the scope of the report, helicobacter pylori is a gram-negative aerobic bacterium commonly found in the stomach which plays a key role in balancing stomach ecology. The Helicobacter Pylori Diagnostics Market is segmented by Technology (Immunoassays, Point of Care (POC), Molecular Diagnostics, and Others), End User (Hospitals and Clinics, Diagnostics Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Technology | Immunoassays | ||
| Point of Care (POC) | |||
| Molecular diagnostics | |||
| Others | |||
| By End-user | Hospitals and clinics | ||
| Diagnostic laboratories | |||
| Others | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
| Immunoassays |
| Point of Care (POC) |
| Molecular diagnostics |
| Others |
| Hospitals and clinics |
| Diagnostic laboratories |
| Others |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| Australia | |
| South Korea | |
| Rest of Asia-Pacific | |
| Middle East and Africa | GCC |
| South Africa | |
| Rest of Middle East and Africa | |
| South America | Brazil |
| Argentina | |
| Rest of South America |
Helicobacter Pylori Diagnostics Market Research FAQs
What is the current Global Helicobacter Pylori Diagnostics Market size?
The Global Helicobacter Pylori Diagnostics Market is projected to register a CAGR of 7.2% during the forecast period (2025-2030)
Who are the key players in Global Helicobacter Pylori Diagnostics Market?
Thermo Fisher Scientific, Quest Diagnostics Incorporate, Meridian Bioscience, Bio-Rad Laboratories and CerTest BIOTEC are the major companies operating in the Global Helicobacter Pylori Diagnostics Market.
Which is the fastest growing region in Global Helicobacter Pylori Diagnostics Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Global Helicobacter Pylori Diagnostics Market?
In 2025, the North America accounts for the largest market share in Global Helicobacter Pylori Diagnostics Market.
What years does this Global Helicobacter Pylori Diagnostics Market cover?
The report covers the Global Helicobacter Pylori Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Helicobacter Pylori Diagnostics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Helicobacter Pylori Testing Industry Report
Statistics for the 2025 Global Helicobacter Pylori Diagnostics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Helicobacter Pylori Diagnostics analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
